Kenvue Inc.
Regulated industryPhysical productsConsumer brandTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $19.56
- 52-Week Range
- $15.94 – $20.13
- Market Cap
- $37.11B
- P/E (TTM)
- 21.94
- EPS (TTM)
- 0.88
- Dividend Yield
- 4.35%
Advanced Metrics
- Price/Book
- 3.65
- PEG Ratio
- 1.53
- Return on Equity
- 16.25%
- Return on Assets
- 7.03%
- Gross Margin
- 58.53%
- Operating Margin
- 19.22%
- Profit Margin
- 10.88%
- Current Ratio
- 0.95
- Debt/Equity
- 0.82
- Total Debt
- $8.34B
- Free Cash Flow
- $2.77B
- Revenue Growth
- 3.20%
- Earnings Growth
- 6.00%
- Enterprise Value
- $44.41B
Market Snapshot
About
Kenvue Inc. is a consumer health company formed through Johnson & Johnson's spin-off of its consumer health business. The company owns a portfolio of well-known brands including Tylenol, Listerine, Johnson's Baby, Band-Aid, Neutrogena, and Aveeno. Kenvue focuses on self-care products across skin health and beauty, essential health, and personal care categories, serving consumers in more than 100 countries worldwide.